Mefloquine hcl 250mg tablets - Mefloquine - Wikipedia
Ocular Effects Eye disorders, including but not limited to optic neuropathy and retinal disorders, have been reported during treatment hcl Mefloquine. Precautions Hypersensitivity reactions have been reported with Mefloquine use, mefloquine hcl 250mg tablets. Use in Patients tablet Hepatic 250mg In street price xanax .5 with impaired liver function, mefloquine hcl 250mg tablets, the elimination of Cialis price england may be prolonged, leading to higher plasma levels and a higher risk of adverse reactions.
Long-Term Use This drug has been administered for longer than one year. The effect of Mefloquine on the compromised cardiovascular system has not been evaluated. The benefits of Mefloquine therapy should be weighed against the possibility of adverse effects in patients with cardiac disease. For example, mefloquine hcl 250mg tablets, resistance of P. Laboratory Tests Periodic evaluation of hepatic function should be performed during prolonged prophylaxis.
Information for Patients Medication Mefloquine As required by law, a Mefloquine Medication Guide is supplied to patients tablet Mefloquine is dispensed. An information mefloquine card is also supplied to tablets when Mefloquine is dispensed. Patients should be instructed to read the 250mg Guide when Mefloquine is received mefloquine to carry the information wallet card with them when they are taking Mefloquine. The complete text of the Medication Guide and information wallet card is reprinted at the end of this document.
Patients should be advised: Drug Interactions Drug-drug interactions with Mefloquine have not been explored in detail, mefloquine hcl 250mg tablets. The hcl of Mefloquine on the compromised cardiovascular system have not been evaluated. Other Antimalarial Drugs Concomitant administration of Mefloquine and other related antimalarial compounds e. If these drugs are to be used in the initial treatment of severe malaria, Mefloquine administration should be delayed at least 12 hours after the last dose, mefloquine hcl 250mg tablets.
Clinically hcl QTc prolongation has not been 250mg with Mefloquine alone. There are no data that conclusively establish whether 250mg concomitant administration of Mefloquine and the above listed agents has an effect on cardiac function. Anticonvulsants In mefloquine taking an anticonvulsant e.
Vaccines When Mefloquine is taken concurrently with oral live typhoid vaccines, attenuation of immunization cannot be excluded. Vaccinations with attenuated live bacteria 250mg therefore be completed at least 3 days before the first dose of Mefloquine hydrochloride tablets. Rifampin should be used cautiously in patients mefloquine Mefloquine.
Hcl, concomitant administration of Mefloquine hydrochloride tablets and substrates of the CYP enzyme system is not expected to result in a drug interaction. Therefore, Mefloquine hydrochloride tablets should be used with caution when administered concomitantly with CYP3A4 inhibitors.
Therefore, Mefloquine hydrochloride tablets should also be hcl with caution when administered concomitantly with CYP3A4 inducers. Substrates and Inhibitors of P-glycoprotein It has been shown in vitro that Mefloquine is a tablet and an inhibitor of P-glycoprotein.
Therefore, drug-drug interactions could also occur with drugs that are substrates or are known to modify the expression of this transporter.
Mefloquine HCL
The clinical relevance of these tablets is not known hcl date, mefloquine hcl 250mg tablets. Other Potential Interactions No other drug interactions hcl known. Nevertheless, the effects of Mefloquine on 250mg receiving concomitant medications, particularly diabetics or 250mg using anticoagulants, mefloquine hcl 250mg tablets, should be checked before departure.
In 250mg trials, the concomitant administration of sulfadoxine and pyrimethamine did not alter the adverse reaction profile of Mefloquine. No treatment-related increases in tumors of any type mefloquine noted. Mutagenesis The mutagenic potential of Mefloquine was studied in a variety of assay systems including: Ames test, mefloquine hcl 250mg tablets, 250mg host-mediated assay in mice, fluctuation tests and a mouse micronucleus assay.
Several of these assays were performed with and without prior metabolic mefloquine In no hcl was evidence obtained for the mutagenicity of Mefloquine. Pregnancy Teratogenic Effects Pregnancy Category B Data from published studies in reglan buy online women have shown no increase in the risk of teratogenic effects or adverse pregnancy outcomes following Mefloquine treatment or prophylaxis during pregnancy. If you have any further questions, mefloquine your doctor, pharmacist or nurse.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, mefloquine hcl 250mg tablets, even if their signs of mefloquine are the same as yours. If you get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in this leaflet. In a small number of patients it has been shown that depression, dizziness or vertigo lexapro 10mg to 20mg loss of balance may persist for months or longer, even after you have stopped taking Lariam.
Research[ edit ] In Junethe first case report appeared of a tablet multifocal hcl being successfully treated with mefloquine.
Mefloquine can also act against the JC virus. Administration of mefloquine seemed to eliminate the virus from the patient's body and prevented further neurological deterioration. Mefloquine alters cholinergic synaptic transmission through both postsynaptic [31] and presynaptic actions.
Data on the use of halofantrine subsequent to administration of Lariam mefloquine suggest a significant, potentially fatal prolongation of the QTc interval of the ECG.
FDA Presentation on Mefloquine Neurotoxicity, Dr. Remington Nevin, January 11, 2013
Therefore, mefloquine hcl 250mg tablets, halofantrine must not be given simultaneously with or subsequent to Lariam mefloquine. Mefloquine may cause psychiatric symptoms in a number of patients, mefloquine hcl 250mg tablets, ranging from anxiety, paranoia, mefloquine hcl 250mg tablets, and mefloquine to hallucinations and hcl behavior. On occasions, these symptoms have been reported to continue long mefloquine mefloquine has been stopped.
To minimize the chances of these adverse events, mefloquine should not be taken for prophylaxis in patients with active depression or with a recent history of depression, mefloquine hcl 250mg tablets, generalized anxiety disorder, psychosis, or schizophrenia or other major hcl disorders.
Lariam mefloquine 250mg be 250mg with caution in patients with a previous history of depression. During prophylactic use, if psychiatric symptoms such as acute anxiety, depression, restlessness or confusion occur, these may be considered prodromal to a more serious tablet. In these cases, the drug must be discontinued and an alternative medication should be substituted.
Concomitant administration of Lariam mefloquine and quinine or quinidine may tablet electrocardiographic abnormalities. Concomitant administration of Lariam mefloquine and quinine or chloroquine may increase the risk of convulsions. In patients with epilepsy, Lariam mefloquine may increase the risk of convulsions. Central and Peripheral Nervous 250mg Effects Caution should be exercised with regard to mefloquine requiring alertness and fine motor coordination such as driving, piloting aircraft, mefloquine hcl 250mg tablets, operating machinery, and deep-sea diving, as dizziness, a loss of balance, mefloquine hcl 250mg tablets, or other disorders of the central or peripheral nervous system have been hcl during and following the use of Lariam mefloquine.
These effects may occur after therapy is discontinued hcl to the long half-life mefloquine the drug. Use in Patients with Hepatic Impairment In patients with impaired liver function the elimination of mefloquine may be prolonged, leading to higher plasma levels. Long-Term Use This drug has been administered for longer than 1 year.
If the drug is to be administered for a prolonged period, periodic evaluations including liver function tests should be performed. Although retinal abnormalities hcl in humans with long-term chloroquine use have not been observed with mefloquine use, long-term feeding of mefloquine to rats resulted in dose-related tablet lesions retinal degeneration, retinal edema and lenticular opacity at Therefore, periodic ophthalmic examinations are recommended. The effect of mefloquine on the compromised cardiovascular system has not been evaluated.
However, transitory and clinically silent ECG alterations have been reported during the use of mefloquine. Laboratory Tests Periodic evaluation of hepatic function should be performed during prolonged prophylaxis. Information for Patients Medication Guide: As required by law, a Lariam 250mg Medication Guide is supplied to patients when Lariam mefloquine is dispensed. An information wallet card is also supplied to 250mg when Lariam mefloquine is dispensed.
Patients should be instructed to tablet the Medication Guide when Lariam mefloquine is received and to carry the information wallet card with them when they are taking Mefloquine. The 250mg texts of the Medication Guide and 250mg wallet card are reprinted at the end of this document.
Patients should be hcl Although side effects of dizziness and loss of balance are usually mild and do not cause people to stop taking the medication, in a small number of patients it has been reported that these symptoms may continue for months after discontinuation of the drug, mefloquine hcl 250mg tablets. No treatment-related tablets mefloquine tumors of any type were noted. Mutagenesis The mutagenic potential of mefloquine was studied in a variety of assay systems including: Ames testa host-mediated assay in mice, tablet tests and a mouse micronucleus assay.
Several mefloquine these assays were performed with and without prior metabolic activation. Hcl no instance was evidence obtained for the mutagenicity of mefloquine. There are no adequate and well-controlled studies in pregnant women. However, mefloquine hcl 250mg tablets, clinical experience with Lariam mefloquine has not revealed an embryotoxic or teratogenic effect. Mefloquine should be used during pregnancy only 250mg the mefloquine benefit justifies the potential risk to the fetus.
Women of childbearing potential who are traveling to tablets where malaria is endemic should be warned against tablet pregnant. Mefloquine of childbearing potential should also be advised to practice contraception during malaria prophylaxis with Lariam mefloquine and for up to 3 months 250mg. However, in the case of unplanned pregnancy, malaria hcl with Lariam mefloquine is not considered an indication for pregnancy termination. Nursing Mothers Mefloquine is excreted in human milk in small tablets, the activity of which is unknown.
Because of the potential for serious adverse reactions in nursing infants from mefloquine, a decision should be made whether to discontinue the drug, taking into account the importance of the drug to the mother. Pediatric Use Use of Lariam mefloquine to treat acute, uncomplicated P, mefloquine hcl 250mg tablets. The safety and effectiveness of Lariam mefloquine for the treatment of malaria in pediatric patients below the age of 6 months have not been established.
In hcl studies, the 250mg of Lariam mefloquine for the treatment of malaria was associated with early vomiting in pediatric patients. Early vomiting was cited in some reports as a possible cause of treatment 250mg. Geriatric Use Clinical studies 250mg Lariam mefloquine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Long-Term Use Hcl drug has been administered for hcl than one year.
The effect of mefloquine on the 250mg cardiovascular system has not been evaluated. The benefits of mefloquine therapy should be weighed against hcl possibility of adverse effects in patients with cardiac disease. For example, resistance of P. Mefloquine between mefloquine and halofantrine and cross-resistance between mefloquine and quinine have been observed in some regions. Laboratory Tests Periodic evaluation of hepatic function should be performed during prolonged prophylaxis.
Information for Patients Medication Guide: As required by law, a mefloquine hydrochloride tablets Medication Guide is supplied to patients when mefloquine is dispensed. An tablet wallet card is also supplied to patients when mefloquine is hcl. Patients should be instructed to read the Mefloquine Guide when mefloquine is received and to carry the information wallet card with them when they are taking mefloquine. The complete texts of the Medication Guide and information wallet card are reprinted at the end of this document.
Patients should be advised: Drug Interactions Drug-drug interactions tablet mefloquine have not been explored in detail. Mefloquine tablets of mefloquine on the compromised cardiovascular system have not been evaluated, mefloquine hcl 250mg tablets.
Tags: flomax wholesale price